Chronic Pain
Conditions
Keywords
Chronic Pain
Brief summary
To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.
Interventions
DEVICECommercially Approved Interventional Medical Device/Therapy for Chronic Pain
Commercially Approved Interventional Medical Device/Therapy
Sponsors
Boston Scientific Corporation
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Key Inclusion Criteria: * Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting * Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening * Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English Key
Exclusion criteria
* Requires a legal representative to sign the ICF ascertained from self-reporting
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Targeted Pain Responder Rate | up to 40 months post study enrollment | Percentage of subjects with a 50 percent or greater reduction in targeted pain intensity, based on self-reported percent pain relief |
Countries
United States
Contacts
STUDY_DIRECTORNatalie B Lyons
Boston Scientific Corporation
Outcome results
None listed